Judy Shih

Judy Shih, MD, PhD, is a seasoned medical professional with extensive experience in endocrinology and global patient safety. Currently serving as the Global Development Medical Director for Late-stage Cardiovascular Renal Metabolism at AstraZeneca, Judy's previous roles include Medical Director for Global Patient Safety in Type 1 Diabetes and Associate Medical Director for Global Patient Safety in Cystic Fibrosis at Vertex Pharmaceuticals. Additionally, Judy has worked as an endocrinologist at ENDOCRINOLOGY DIABETES & METABOLISM and Harvard Vanguard Medical Associates, and has contributed as an Instructor in Medicine at Harvard Medical School.